Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral bromelain in COVID-19 positive patients
DRKS00025783Phase 2Completed
- Sponsor
- URSAPHARM
- Start
- Jul 2021
- Modality
- Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of bromelain in coronavirus disease 2019 (COVID-19) (4 arms), sponsored by URSAPHARM. Started Jul 2021; status: completed.
02
Drugs
bromelain
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on DRKS00025783.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00025783.